Current status: 1050 hESC lines, 6624 hiPSC lines, and 158 clinical studies, and 2344 certificates
Monthly statistic from Nov 1, 2024
Posted on November 1, 2024
| total lines | 7674 |
| hESC lines | 1050 |
| hiPSC lines | 6624 |
| derivation countries | 50 |
| projects | 310 |
| providers | 940 |
| clinical studies | 158 |
| subclones | 3193 |
| certificates | 2344 |
| cell line certificates | 2198 |
| project certificates | 146 |